Microlife-Website-technology

For Diabetic Patients

For Diabetic Patients

Patients with Diabetes Mellitus type 1 and 2 may have stiff arteries that can affect the blood pressure measurement. A recent validation study in diabetes patients type 1 and 2 showed that the Circa 120/80 monitors are accurate when used in this patient group. Accurate Measurement for Diabetes.

For End-Stage Renal Disease Patients:

For End-Stage Renal Disease Patients

Patients with renal disease have a very high incidence of hypertension, paired with stiff (calcified) arteries. As automated measurements are often inaccurate in patients with stiff arteries, a special validation is required.

Circa 120/80 monitors are validated to measure blood pressure in ERD patient. Validated blood pressure for patients with end-stage renal disease patients.

For pre-eclampsia patients:

For pre-eclampsia patients

Pre-eclampsia is defined as new hypertension after 20 weeks gestation. Due to the unpredictable nature of pre-eclampsia blood pressure must be constantly checked.

Most blood pressure monitors underestimate blood pressure in pre-eclampsia and therefore must be specifically validated for this special patient group. Circa 120/80 allows pregnant women to measure their blood pressure at home which could reduce the number of hospital visits and may help to make motherhood safer. Microlife’s WatchBP Home is accurate for use in pregnancy and Pre-eclampsia.

Follows International Guidelines

Follows International Guidelines

Protocols of Home Blood pressure monitoring recommended by leading global bodies AHA ESH BIHS have been incorporated in Circa 120/80.

PAD Technology:

Gives an early alerts to possible heart arrhythmias.

The PAD technology (Pulse Arrhythmia Detection) analyses pulse frequency and detects irregular heartbeats during blood pressure measurement. If an irregular heartbeat occurs during the measure heartbeat occurs during the measurement, the PAD symbol will be displayed. PAD is not a replacement cardiac examination, but it serves as a means to detect pulse irregularities at an early stage.

pad-logo

Advantages of PAD technology:

All Microlife blood pressure monitors with PAD technology detect heart arrhythmias during a blood pressure measurement without the need for any adjustments. Unlike most blood pressure monitors, Microlife devices can distinguish between arrhythmias and artefacts due to its great technical and physiological precision in measurements.

What is Gentle+?

The Gentle+ technology improves the inflation and deflation rate during blood pressure measurements. It is an adaptive pressure control technology which allows optimal speed and pressure control for a comfortable measurement.

Gentle+ analyses the blood pressure signals during inflation to calculate the

gentle

required pressure level so that overinflation, which may be painful and increase BP value, can be prevented.

Advantages of Gentle+ at a glance:

- Comfortable measurements

- Less overinflation